节点文献

胸腔内高温灌注化学治疗恶性胸腔积液

Treatment of Malignant Pleural Effusion Caused by Lung Cancer with Thoracoscopic Intrapleural Perfusion Hyperthermo-chemotherapy

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 冯兴; 李浒; 王国卿; 章希贤; 毛宝根;

【Author】 FENG Xing1, LI Hu1, WANG Guo-qing1, ZHANG Xi-xian1,MAO Bao-gen2. (1.Department of Thoracic Surgery, Hangzhou First People’s Hospital, Hangzhou 310006, P.R.China.; 2.Department of Cardiovascular Surgery, Hangzhou First People’s Hospital, Hangzhou 310006, P.R.China)

【机构】 杭州市第一人民医院胸外科; 杭州市第一人民医院心脏外科 杭州310006; 杭州310006;

【摘要】 目的总结电视胸腔镜辅助下胸腔内高温灌注化学治疗恶性病变引起的胸腔积液的方法和效果。方法1999年2月至2005年3月,将58例恶性胸腔积液患者随机分为治疗组(30例)和对照组(28例),治疗组在全身麻醉电视胸腔镜下行胸膜活检术,并用人工心肺机恒温43℃,生理盐水3000ml加顺铂300mg灌注1h;对照组予以胸腔引流,胸腔内灌注顺铂60~80mg。比较两组治疗前、后胸水量的变化、胸水中癌胚抗原(CEA)、细胞角蛋白K19片段(CYFRA21-1)、神经元特异性烯醇化酶(NSE)浓度变化和毒副作用。结果治疗组、对照组有效率分别为100.0%和53.6%,差异有统计学意义(χ2=3.863,P<0.05);治疗组治疗后较治疗前胸水中CEA,CYFRA21-1,NSE浓度明显下降(t=2.562,P<0.05),治疗后治疗组较对照组明显降低(P<0.05);两组各种毒副反应比较差异无统计学意义(P>0.05)。结论电视胸腔镜辅助下胸腔内高温灌注化学治疗恶性胸腔积液安全有效,具有创伤小、视野大、活检准确方便、便于确诊的优点。

【Abstract】 Objective To summarize the method and effective result of thoracoscopic intrapleural perfusion hyperthermo-chemotherapy(TIPHC) for treating malignant pleural effusion caused by lung cancer. Methods Fifty-eight patients with malignant pleural effusion caused by lung cancer were randomly divided into therapeutic group(30 cases) and control group(28 cases) between February 1999 and March 2005. Pleural biopsy and TIPHC under general ansthesia with unilateral ventilation were performed in the therapeutic group, and intrapleural injection of cisplatin was administered in control group after drainage of pleural effusion. The effect on malignant pleural effusion, the change for the concentration of carcino-embryonic antigen(CEA), cytokeratin-19 fragments (CYFRA21-1), neuron-specific enolase (NSE) and the side effect were compared before and after the treatment. Results The therapeutic group achieved total response rate of 100.0%, but only 53.6% in control group, with significant difference(χ2=3.863, P<0.05). Furthermore, the concentration of CEA, CYFRA21-1, NSE in therapeutic group dramatically descended than control group(t=2.562,P<0.05). But there was no significant difference in side effect (P>0.05). The pathological diagnosis of all the patients were determined in the therapeutic group. Conclusion TIPHC has the advantage of both diagnosis and treatment of malignant pleural effusions. It is safe and effective, and also able to determine the diagnosis. Furthermore, it offers the superiority of small wound, best visualization and convenient pleural biopsy.

  • 【文献出处】 中国胸心血管外科临床杂志 ,Chinese Journal of Clinical Thoracic and Cardiovascular Surgery , 编辑部邮箱 ,2007年03期
  • 【分类号】R734
  • 【被引频次】4
  • 【下载频次】56
节点文献中: 

本文链接的文献网络图示:

本文的引文网络